Kyle Kampman, MD

Additional Information & Contact: Dept. of Psychiatry link

Bio 

Dr. Kyle Kampman graduated from Northwestern University in 1981 and Tulane University School of Medicine in 1985.  He interned at the National Naval Medical Center at Bethesda Maryland and served as a medical officer in the United States Navy from 1985 until 1990.  He came to the University of Pennsylvania and served as a resident in Psychiatry from 1990 until 1993.  He then completed a fellowship in Addiction Psychiatry.  In 1994 he joined the faculty in the Department of Psychiatry as an assistant professor. He was promoted to associate professor in 2003 and to professor in 2012. Dr. Kampman has had extensive experience in the treatment of alcohol cocaine and opiate dependence.  He chaired the committee that wrote the ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. He has conducted a number of trials testing medications for the treatment of cocaine alcohol and opiate dependence and is a recognized authority on the cocaine withdrawal syndrome. In addition to research, he works at the Addiction Recovery Unit of the Philadelphia VA Medical Center where he continues to treat cocaine, alcohol, and opiate dependent patients with both medications and psychotherapy.

Selected Publications

Kampman, K.M., Pettinati, H., Lynch, K.G., Dackis, C., Sparkman, T., Weigley, C., O’Brien, C.P.: A pilot trial of topiramate for the treatment of cocaine dependence. Drug and Alcohol Dependence 75:233-240, 2004.

Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend. 2013 Nov 1;133(1):94-9

Kampman KM, Lynch KG, Pettinati HM, Spratt K, Wierzbicki MR, Dackis C, O'Brien CP. A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence. Drug Alcohol Depend. 2015 Oct 1;155:105-10.

ASAM Guideline Committee, Kampman, K.M. (Committee Chair), National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use, American Society of Addiction Medicine, Chevy Chase, 2015.

Kampman, K. Pharmacotherapy for stimulant use disorders in adults. In: UpToDate, Saxon, AJ (Ed), UpToDate, Waltham, MA.

ASAM Guideline Committee, Kampman, K.M. (Committee Chair), The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder 2019 Focused Update, American Society of Addiction Medicine, Chevy Chase, 2019.

Kampman, KM. The treatment of cocaine use disorder. Sci Adv. 2019 Oct 16;5(10).

Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Mahony AL, Brooks DJ, Bisaga A, Dakwar E, Carpenter KM, Naqvi N, Nunes EV, Kampman K. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug Alcohol Depend. 2020;206:107700.

Kampman, K. Pharmacotherapy for stimulant use disorders in adults. In: UpToDate, Saxon, AJ (Ed), UpToDate, Waltham, MA.


Grants & Funding

  • U54DA039002-01 (Kampman) NIH/NIDA Center for the Development of Novel Medications for Cocaine Dependence.
  • UG3DA049694 (Kampman and Woody) Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
  • UG1 DA050209 (Kampman and Childress) A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders.
  • UF1MH121944 (Mandell, Bogner, Kampman) The whole health study: collaborative care for OUD and mental health condition.

Back to Top